Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Goodwill & Intangibles: 2017-2025

Historic Goodwill & Intangibles for Adma Biologics (ADMA) over the last 9 years, with Sep 2025 value amounting to $4.0 million.

  • Adma Biologics' Goodwill & Intangibles fell 55.79% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 55.79%. This contributed to the annual value of $4.0 million for FY2024, which is 54.38% down from last year.
  • As of Q3 2025, Adma Biologics' Goodwill & Intangibles stood at $4.0 million, which was down 0.89% from $4.1 million recorded in Q2 2025.
  • Adma Biologics' Goodwill & Intangibles' 5-year high stood at $9.6 million during Q1 2021, with a 5-year trough of $4.0 million in Q1 2025.
  • For the 3-year period, Adma Biologics' Goodwill & Intangibles averaged around $7.0 million, with its median value being $8.5 million (2023).
  • As far as peak fluctuations go, Adma Biologics' Goodwill & Intangibles rose by 6.55% in 2024, and later slumped by 55.79% in 2025.
  • Adma Biologics' Goodwill & Intangibles (Quarterly) stood at $8.5 million in 2021, then rose by 0.00% to $8.5 million in 2022, then rose by 2.46% to $8.7 million in 2023, then tumbled by 54.38% to $4.0 million in 2024, then plummeted by 55.79% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.1 million for Q2 2025, and $4.0 million during Q1 2025.